SLSN

Business Context and Reporting Period

Company: Nanophase Technologies Corporation (NANX)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Business Overview: Nanophase is a developer and commercial manufacturer of engineered nanomaterials used in diverse markets including sunscreens, personal care, architectural coatings, semiconductor polishing, and water filtration. The company operates manufacturing facilities in Romeoville and Burr Ridge, Illinois, utilizing proprietary technologies (PVS and NanoArc Synthesis) to produce nanoparticles. It relies heavily on strategic partnerships with major chemical companies (BASF, Rohm & Haas, Altana Chemie) for distribution and market access.

Key Financial Metrics (Year Ended Dec 31, 2007)

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 36% to $12.2 million, driven primarily by increased sales to three key customers (BASF, architectural coatings customer, and BYK-Chemie), which collectively accounted for 86.3% of total revenue.
• Profitability Improvement: Net loss narrowed by 31% to $3.6 million. Gross margin expanded to 26.0% from 21.5% due to increased revenue volume absorbing fixed manufacturing costs and favorable product mix.
• Liquidity Position: Total cash and investments more than doubled to $16.7 million, bolstered by a July 2007 equity offering that raised approximately $11.2 million in gross proceeds.
• Expense Management: Research and Development (R&D) expenses decreased 17% to $1.77 million. Selling, General, and Administrative (SG&A) expenses increased slightly by 2.4% to $5.43 million.

Guidance, Outlook, Risks, and Contingencies

• Outlook: Management expects continued revenue growth in 2008, particularly in sunscreen, personal care, and semiconductor polishing markets. The company anticipates maintaining positive gross margins but notes that absolute dollar gross margin growth depends on revenue volume and the ability to pass through raw material cost increases.
• Capital Requirements: The company believes its current cash position and interest income are sufficient to fund operations for the foreseeable future. Capital spending for 2008 is estimated at approximately $700,000.
• Key Risks:
  • Customer Concentration: Extreme reliance on three customers (86% of revenue). Loss of any single customer could materially harm operations.
  • Contractual Triggers: Supply agreements with BASF and RHEM contain "triggering events" (e.g., negative earnings combined with cash/investments below $2 million, or insolvency) that could force the company to license technology or sell production equipment to customers.
  • Intellectual Property: In February 2008, the USPTO cancelled all claims in a key patent (No. 6,669,823 B1) regarding the NanoArc Synthesis process following reexamination. Management does not believe this materially alters the competitive environment but limits legal protection.
  • Liquidity of Investments: The company holds approximately $6 million in Auction Rate Securities (ARS) purchased post-year-end that have experienced "failed auctions," creating potential liquidity constraints if funds are needed immediately.

Investor Verification Checklist

• Customer Concentration: Verify the stability of relationships with BASF, BYK-Chemie, and the architectural coatings customer, which represent the vast majority of revenue.
• Patent Status: Assess the impact of the USPTO cancellation of Patent No. 6,669,823 B1 on the company's competitive moat and future royalty potential.
• Liquidity Covenants: Monitor cash and investment balances to ensure they remain well above the $2 million threshold required to avoid triggering equipment sale clauses in the BASF supply agreement.
• Auction Rate Securities: Review the status of the $6 million ARS holdings for potential liquidity restrictions or valuation adjustments.
• Path to Profitability: Evaluate whether revenue growth rates are sufficient to cover the high fixed cost structure and achieve net income, given the history of cumulative losses ($66.3 million).